Caffeine for Apnea of Prematurity (CAP)

计划入组 2,000 人 · 首次发布于 2005 年 9 月 16 日

Non-invasive Intervention for Apnea of Prematurity

计划入组 19 人 · 首次发布于 2015 年 12 月 29 日

Clinical Study of Caffeine for Apnea of Prematurity

计划入组 24 人 · 首次发布于 2011 年 8 月 3 日

APNEA (Novartis AG)

S-600918 + Concomitant drug X

OF-6145

National Bank of Canada

United Kingdom

Canadian Imperial Bank of Commerce

FACULTY OF MEDICINE, UNIVERSITY OF KELANIYA

Sri Lanka

Enalare Therapeutics Receives FDA Clearance for Phase 1 Study of ENA-001 in the US

FDA Grants Orphan Drug Designation to SignaBlok's TREM-1 Inhibitor for Retinopathy of Prematurity

Placental Evaluation Enhances Risk Assessment for Retinopathy of Prematurity